Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* coding sequence of KCNJ11 or ABCC8 in patients having a permanent neonatal diabetes mellitus~* written informed consent~Exclusion Criteria:~* hypersensibility of sulfonylureas~* severe renal failure (clearance of creatinemia \< 30 ml/min)~* severe hepatic failure (Prothrombin rate \< 70 %)~* Porphyria~* imidazol treatments~* pregnancy~* no social security affiliation

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Glibenclamide

Based on this trial design, predict the completion outcome and termination type (if applicable).